Although SARS-CoV-2 genetic material may still be detected in respiratory or stool samples for several weeks, no live virus (that can cause infection) was found in any type of sample collected beyond nine days of symptoms ...
Nov 20, 2020
0
183
(HealthDay)—The U.S. Food and Drug Administration late Friday approved three new medications to help people battle type 2 diabetes.
Jan 26, 2013
1
3
As public health experts cautiously anticipate how COVID-19 will play out this fall, a University at Buffalo scientist is reiterating that substantial immunity against the SARS-CoV-2 virus will only happen with a vaccine ...
Sep 13, 2022
0
42
Researchers from Vanderbilt University Medical Center (VUMC) are conducting a clinical trial to determine whether nasal saline irrigations can reduce viral shedding and symptoms in patients with COVID-19.
Sep 3, 2020
0
4
(HealthDay)—The U.S. Food and Drug Administration has expanded the approval of Skyrizi (risankizumab-rzaa) to treatment of adults with active psoriatic arthritis, the manufacturer announced Friday.
Jan 26, 2022
0
1
Upper respiratory infections remain one of the most common triggers of asthma attacks in children, but not every cold leads to a dangerous worsening of symptoms, even among children with severe asthma. The reasons for this ...
Apr 23, 2019
0
167
When was the last time you walked into a public space and didn't hear someone coughing? After three years of flinching at the sound, it can be disarming to hear so many people coughing—and embarrassing if it's you.
Feb 10, 2023
0
3
Taking probiotics seems to provide both children and adults with a mild degree of protection against many upper respiratory tract infections including the common cold, according to a new systematic review. People who consume ...
Sep 16, 2011
0
0
Understanding how viral infection occurs can provide important clues for researchers to develop strategies to prevent viral transmission and develop effective therapeutic agents and vaccines. SARS-CoV-2, the causative agent ...
Jul 1, 2021
0
36
Researchers at the University of Georgia have used a virus commonly found in dogs as the foundation for a new vaccine against H7N9 influenza, more commonly known as bird flu.
May 6, 2015
0
144
